molecules-logo

Journal Browser

Journal Browser

Innovative Drug Discovery and Mechanism Studies Based on Phenotypic Screening

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 361

Special Issue Editors


E-Mail Website
Guest Editor
Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
Interests: medicinal chemistry; drug design; drug discovery; phenotypic screening; artificial intelligence; chemical biology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
Interests: medicinal chemistry; chemical biology; computational chemistry; design and discovery of protein degraders

Special Issue Information

Dear Colleagues,

Phenotype-based screening uses an unbiased approach to find compounds that modify the outcome of a particular cell or organism of interest. It has the advantage of identifying drug leads that possess therapeutic potential for diseases with unknown or complex mechanisms. Phenotypic screening approaches have led to the discovery of several new molecular entities; some of them are first-in-class and have been approved for medications such as Sirolimus, Daptomycin, Artemether, Fingolimod, etc. Moreover, new bioactive compounds have inspired researchers to identify novel mechanisms that trigger biological effects for disease treatment.

With this Special Issue, we are pleased to invite our colleagues to present their findings in the field of phenotypic-screening-based drug discovery. In particular, articles reporting novel mechanisms of new active compounds are encouraged. This Special Issue aims to provide the most updated insights into phenotypic-screening-based drug discovery, and original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: the development of new phenotypic screening approaches, bioactivity screening of compound libraries, the discovery of novel bioactive lead compounds, druggability research, structure–activity relationship studies, proteomics-based mechanism studies and target identification, reverse docking and molecular modeling.

We look forward to receiving your contributions.

Prof. Dr. Jinxin Che
Prof. Dr. Chengliang Zhu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug discovery
  • phenotypic screening
  • mechanism study
  • structure–activity relationship study
  • molecule docking and modeling
  • target identification

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop